These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35908449)

  • 1. Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD).
    Shosha E; Aljarallah SA; Al Fugham N; Al-Jedai AH; Al Luqmani MM; Al Malik YM; Al Mudaiheem HY; Al Otaibi HS; Al Thekair FY; Al Thubaiti IA; Al Yafeai RH; Ben Slimane NS; Bunyan RF; Cupler EJ; Mubarki SM; Saeedi JA; Al Jumah MA
    Mult Scler Relat Disord; 2022 Oct; 66():104062. PubMed ID: 35908449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
    Kümpfel T; Giglhuber K; Aktas O; Ayzenberg I; Bellmann-Strobl J; Häußler V; Havla J; Hellwig K; Hümmert MW; Jarius S; Kleiter I; Klotz L; Krumbholz M; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Trebst C; Tumani H; Warnke C; Wildemann B; Berthele A;
    J Neurol; 2024 Jan; 271(1):141-176. PubMed ID: 37676297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
    Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
    Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia.
    Algahtani H; Shirah B; Ibrahim B; Malik YA; Makkawi S
    Mult Scler Relat Disord; 2021 Jan; 47():102668. PubMed ID: 33307475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the management of neuromyelitis optica spectrum disorder.
    Bruscolini A; La Cava M; Mallone F; Marcelli M; Ralli M; Sagnelli P; Greco A; Lambiase A
    Expert Rev Neurother; 2019 Nov; 19(11):1127-1133. PubMed ID: 31339052
    [No Abstract]   [Full Text] [Related]  

  • 8. A comprehensive review of the advances in neuromyelitis optica spectrum disorder.
    Siriratnam P; Huda S; Butzkueven H; van der Walt A; Jokubaitis V; Monif M
    Autoimmun Rev; 2023 Dec; 22(12):103465. PubMed ID: 37852514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
    Alam M; Haq MAU; Iqbal A; Ullah K; Nabi D
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):379-380. PubMed ID: 30925966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
    Alves Do Rego C; Collongues N
    Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.
    Cotzomi E; Stathopoulos P; Lee CS; Ritchie AM; Soltys JN; Delmotte FR; Oe T; Sng J; Jiang R; Ma AK; Vander Heiden JA; Kleinstein SH; Levy M; Bennett JL; Meffre E; O'Connor KC
    Brain; 2019 Jun; 142(6):1598-1615. PubMed ID: 31056665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments.
    Du Y; Li K; Liu W; Song R; Luo M; He J; Xu X; Qu X
    Curr Pharm Des; 2022; 28(4):272-279. PubMed ID: 33781189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis Optica Spectrum Disorders.
    Costello F
    Continuum (Minneap Minn); 2022 Aug; 28(4):1131-1170. PubMed ID: 35938660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.
    Liu C; Shi M; Zhu M; Chu F; Jin T; Zhu J
    Autoimmun Rev; 2022 Jan; 21(1):102921. PubMed ID: 34384938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
    Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
    Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathobiology, Diagnosis, and Current Biomarkers in Neuromyelitis Optica Spectrum Disorders.
    Fiala C; Rotstein D; Pasic MD
    J Appl Lab Med; 2022 Jan; 7(1):305-310. PubMed ID: 34996075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].
    Aktas O; Kümpfel T
    Nervenarzt; 2021 Apr; 92(4):307-316. PubMed ID: 33728474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.
    Castro-Suarez S; Guevara-Silva E; Osorio-Marcatinco V; Alvarez-Toledo K; Meza-Vega M; Caparó-Zamalloa C
    Mult Scler Relat Disord; 2022 Aug; 64():103919. PubMed ID: 35691236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Tzartos JS; Stergiou C; Kilidireas K; Zisimopoulou P; Thomaidis T; Tzartos SJ
    PLoS One; 2013; 8(9):e74773. PubMed ID: 24086369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.